ChemoSeed®
High-Grade Glioma (Brain Cancer)
Phase I/IIActive
Key Facts
About CRISM Therapeutics
CRISM Therapeutics' mission is to transform oncology care by localizing chemotherapy delivery to improve the therapeutic index and patient quality of life. The company's strategy centers on advancing its proprietary ChemoSeed® implantable drug delivery platform through clinical development, initially targeting high-unmet-need solid tumors like brain and pancreatic cancers. As a public entity, CRISM is focused on generating clinical proof-of-concept to validate its technology and attract potential development or commercial partnerships. Its key achievement is progressing its lead program into clinical trials, positioning it at the forefront of implantable, sustained-release oncology therapeutics.
View full company profile